The vaginal Torquetenovirus titer varies with vaginal microbiota composition in pregnant women.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
09
2021
accepted:
03
01
2022
entrez:
20
1
2022
pubmed:
21
1
2022
medline:
22
2
2022
Statut:
epublish
Résumé
Torquetenovirus (TTV) is a nonpathogenic endogenous virus whose abundance varies with the extent of immune system activation. We determined if the TTV titer in the vagina of pregnant women was associated with vaginal microbiota composition and levels of compounds in vaginal secretions. Vaginal TTV and microbiota composition in 494 second trimester pregnant women were identified by gene amplification and analysis. Vaginal matrix metalloproteinases (MMPs), tissue inhibitors of MMP (TIMP) and lactic acid isomers were measured by ELISA. Dominance was defined as the relative abundance of a specific bacterium or species at >50% of the total number of bacteria identified. Clinical data were obtained by chart review. The median log10 TTV titer was lowest when Lactobacillus species other than L. iners were dominant (<1.0) as compared to when L. iners (4.1, p = 0.0001), bacteria other than lactobacilli (4.5, p = 0.0016) or no bacterium (4.7, p = 0.0009) dominated. The TTV titer was inversely proportional to L. crispatus abundance (p<0.0001) and directly proportional to levels of G. vaginalis (p = 0.0008) and L. iners (p = 0.0010). The TTV titer was proportional to TIMP-1, TIMP-2, MMP-8 and MMP-9 abundance (p≤0.0002) and inversely proportional to the level of D-lactic acid (p = 0.0024). We conclude that the association between variations in the TTV titer and the relative abundance of specific bacterial species and vaginal compounds indicates that local changes in immune status likely influence vaginal fluid composition.
Identifiants
pubmed: 35051215
doi: 10.1371/journal.pone.0262672
pii: PONE-D-21-30550
pmc: PMC8775304
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0262672Subventions
Organisme : NIGMS NIH HHS
ID : P30 GM103324
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Sci Rep. 2017 Aug 31;7(1):10201
pubmed: 28860491
J Virol. 2003 Aug;77(16):9081-3
pubmed: 12885924
Front Immunol. 2020 May 27;11:998
pubmed: 32536920
J Matern Fetal Neonatal Med. 2016;29(15):2414-22
pubmed: 26643648
mBio. 2019 Oct 22;10(5):
pubmed: 31641087
Reprod Sci. 2020 Nov;27(11):2075-2081
pubmed: 32944879
Virol J. 2017 May 8;14(1):92
pubmed: 28482844
Am J Transplant. 2020 Aug;20(8):1963-1964
pubmed: 32189426
J Infect Dis. 2014 Aug 15;210(4):667-8
pubmed: 24688076
Clin Infect Dis. 2001 May 1;32(9):1376-7
pubmed: 11303276
Curr Top Microbiol Immunol. 2009;331:21-33
pubmed: 19230555
J Gen Virol. 2015 Jan;96(Pt 1):115-117
pubmed: 25304651
Clin Microbiol Infect. 2000 May;6(5):246-50
pubmed: 11168120
Microbiome. 2014 Feb 03;2(1):4
pubmed: 24484853
PLoS One. 2017 Jul 10;12(7):e0180878
pubmed: 28700733
Front Public Health. 2020 Jul 24;8:326
pubmed: 32793540
J Clin Virol. 1999 Aug;13(3):181-4
pubmed: 10443794
Heliyon. 2020 Nov 21;6(11):e05535
pubmed: 33294681
J Virol. 2001 Dec;75(24):11999-2004
pubmed: 11711590
Sci Rep. 2015 Mar 11;5:8988
pubmed: 25758319
Virology. 2002 Sep 15;301(1):121-9
pubmed: 12359452
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):11060-5
pubmed: 26283357
BJOG. 2017 Mar;124(4):606-611
pubmed: 28224747
mBio. 2013 Aug 06;4(4):
pubmed: 23919998